The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Pulmonary Fibrosis

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Pulmonary Fibrosis


High impact information on Pulmonary Fibrosis


Chemical compound and disease context of Pulmonary Fibrosis


Biological context of Pulmonary Fibrosis


Anatomical context of Pulmonary Fibrosis


Gene context of Pulmonary Fibrosis


Analytical, diagnostic and therapeutic context of Pulmonary Fibrosis


  1. Spontaneous release of interleukin-2 by lung T lymphocytes in active pulmonary sarcoidosis. Pinkston, P., Bitterman, P.B., Crystal, R.G. N. Engl. J. Med. (1983) [Pubmed]
  2. Hermansky-Pudlak syndrome type 7 (HPS-7) results from mutant dysbindin, a member of the biogenesis of lysosome-related organelles complex 1 (BLOC-1). Li, W., Zhang, Q., Oiso, N., Novak, E.K., Gautam, R., O'Brien, E.P., Tinsley, C.L., Blake, D.J., Spritz, R.A., Copeland, N.G., Jenkins, N.A., Amato, D., Roe, B.A., Starcevic, M., Dell'Angelica, E.C., Elliott, R.W., Mishra, V., Kingsmore, S.F., Paylor, R.E., Swank, R.T. Nat. Genet. (2003) [Pubmed]
  3. Essential roles of the Fas-Fas ligand pathway in the development of pulmonary fibrosis. Kuwano, K., Hagimoto, N., Kawasaki, M., Yatomi, T., Nakamura, N., Nagata, S., Suda, T., Kunitake, R., Maeyama, T., Miyazaki, H., Hara, N. J. Clin. Invest. (1999) [Pubmed]
  4. Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene. Eitzman, D.T., McCoy, R.D., Zheng, X., Fay, W.P., Shen, T., Ginsburg, D., Simon, R.H. J. Clin. Invest. (1996) [Pubmed]
  5. Effects of intercellular adhesion molecule 1 (ICAM-1) null mutation on radiation-induced pulmonary fibrosis and respiratory insufficiency in mice. Hallahan, D.E., Geng, L., Shyr, Y. J. Natl. Cancer Inst. (2002) [Pubmed]
  6. A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis. Ziesche, R., Hofbauer, E., Wittmann, K., Petkov, V., Block, L.H. N. Engl. J. Med. (1999) [Pubmed]
  7. The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. Munger, J.S., Huang, X., Kawakatsu, H., Griffiths, M.J., Dalton, S.L., Wu, J., Pittet, J.F., Kaminski, N., Garat, C., Matthay, M.A., Rifkin, D.B., Sheppard, D. Cell (1999) [Pubmed]
  8. Active lung fibrosis up to 17 years after chemotherapy with carmustine (BCNU) in childhood. O'Driscoll, B.R., Hasleton, P.S., Taylor, P.M., Poulter, L.W., Gattameneni, H.R., Woodcock, A.A. N. Engl. J. Med. (1990) [Pubmed]
  9. Delayed pulmonary fibrosis after nitrosourea therapy. Limper, A.H., McDonald, J.A. N. Engl. J. Med. (1990) [Pubmed]
  10. Pulmonary fibrosis and angiotensin I-converting enzyme. Vats, T.S. N. Engl. J. Med. (1980) [Pubmed]
  11. Altered expression of small proteoglycans, collagen, and transforming growth factor-beta 1 in developing bleomycin-induced pulmonary fibrosis in rats. Westergren-Thorsson, G., Hernnäs, J., Särnstrand, B., Oldberg, A., Heinegård, D., Malmström, A. J. Clin. Invest. (1993) [Pubmed]
  12. Cultured lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis have a diminished capacity to synthesize prostaglandin E2 and to express cyclooxygenase-2. Wilborn, J., Crofford, L.J., Burdick, M.D., Kunkel, S.L., Strieter, R.M., Peters-Golden, M. J. Clin. Invest. (1995) [Pubmed]
  13. IL-7 inhibits fibroblast TGF-beta production and signaling in pulmonary fibrosis. Huang, M., Sharma, S., Zhu, L.X., Keane, M.P., Luo, J., Zhang, L., Burdick, M.D., Lin, Y.Q., Dohadwala, M., Gardner, B., Batra, R.K., Strieter, R.M., Dubinett, S.M. J. Clin. Invest. (2002) [Pubmed]
  14. Antitumor and toxic effects of combination chemotherapy with bleomycin and a phenothiazine anticalmodulin agent. Hait, W.N., Lazo, J.S., Chen, D.L., Gallichio, V.S., Filderman, A.E. J. Natl. Cancer Inst. (1988) [Pubmed]
  15. Expression of a tumor necrosis factor-alpha transgene in murine lung causes lymphocytic and fibrosing alveolitis. A mouse model of progressive pulmonary fibrosis. Miyazaki, Y., Araki, K., Vesin, C., Garcia, I., Kapanci, Y., Whitsett, J.A., Piguet, P.F., Vassalli, P. J. Clin. Invest. (1995) [Pubmed]
  16. alpha 1-antitrypsin phenotypes in fibrosing alveolitis and rheumatoid arthritis. Geddes, D.M., Webley, M., Brewerton, D.A., Turton, C.W., Turner-Warwick, M., Murphy, A.H., Ward, A.M. Lancet (1977) [Pubmed]
  17. Global analysis of gene expression in pulmonary fibrosis reveals distinct programs regulating lung inflammation and fibrosis. Kaminski, N., Allard, J.D., Pittet, J.F., Zuo, F., Griffiths, M.J., Morris, D., Huang, X., Sheppard, D., Heller, R.A. Proc. Natl. Acad. Sci. U.S.A. (2000) [Pubmed]
  18. Dibromomannitol in the treatment of chronic granulocytic leukemia: a prospective randomized comparison with busulfan. Canellos, G.P., Young, R.C., Neiman, P.E., DeVita, V.T. Blood (1975) [Pubmed]
  19. Abnormalities of erythrocyte membrane fluidity, lipid composition, and lipid peroxidation in systemic sclerosis: evidence of free radical-mediated injury. Solans, R., Motta, C., Solá, R., La Ville, A.E., Lima, J., Simeón, P., Montellà, N., Armadans-Gil, L., Fonollosa, V., Vilardell, M. Arthritis Rheum. (2000) [Pubmed]
  20. T cell-specific ablation of Fas leads to Fas ligand-mediated lymphocyte depletion and inflammatory pulmonary fibrosis. Hao, Z., Hampel, B., Yagita, H., Rajewsky, K. J. Exp. Med. (2004) [Pubmed]
  21. Augmentation of fibroblast proliferation by bleomycin. Moseley, P.L., Hemken, C., Hunninghake, G.W. J. Clin. Invest. (1986) [Pubmed]
  22. Bleomycin-induced pulmonary fibrosis in hamsters. An alveolar macrophage product increases fibroblast prostaglandin E2 and cyclic adenosine monophosphate and suppresses fibroblast proliferation and collagen production. Clark, J.G., Kostal, K.M., Marino, B.A. J. Clin. Invest. (1983) [Pubmed]
  23. The effects of intrinsic pathway protease deficiencies on plasminogen-deficient mice. Cheng, Q., Zhao, Y., Lawson, W.E., Polosukhin, V.V., Johnson, J.E., Blackwell, T.S., Gailani, D. Blood (2005) [Pubmed]
  24. Regulation of pulmonary fibrosis by chemokine receptor CXCR3. Jiang, D., Liang, J., Hodge, J., Lu, B., Zhu, Z., Yu, S., Fan, J., Gao, Y., Yin, Z., Homer, R., Gerard, C., Noble, P.W. J. Clin. Invest. (2004) [Pubmed]
  25. Transient gene transfer and expression of Smad7 prevents bleomycin-induced lung fibrosis in mice. Nakao, A., Fujii, M., Matsumura, R., Kumano, K., Saito, Y., Miyazono, K., Iwamoto, I. J. Clin. Invest. (1999) [Pubmed]
  26. The neutral cysteine protease bleomycin hydrolase is essential for epidermal integrity and bleomycin resistance. Schwartz, D.R., Homanics, G.E., Hoyt, D.G., Klein, E., Abernethy, J., Lazo, J.S. Proc. Natl. Acad. Sci. U.S.A. (1999) [Pubmed]
  27. Presenilin 2 deficiency causes a mild pulmonary phenotype and no changes in amyloid precursor protein processing but enhances the embryonic lethal phenotype of presenilin 1 deficiency. Herreman, A., Hartmann, D., Annaert, W., Saftig, P., Craessaerts, K., Serneels, L., Umans, L., Schrijvers, V., Checler, F., Vanderstichele, H., Baekelandt, V., Dressel, R., Cupers, P., Huylebroeck, D., Zwijsen, A., Van Leuven, F., De Strooper, B. Proc. Natl. Acad. Sci. U.S.A. (1999) [Pubmed]
  28. Efficacy and toxicity of multiagent chemotherapy and low-dose involved-field radiotherapy in children and adolescents with Hodgkin's disease. Hudson, M.M., Greenwald, C., Thompson, E., Wilimas, J., Marina, N., Fairclough, D., Kauffman, W., Bozeman, P., Mackert, P.W., Abromowitch, M. J. Clin. Oncol. (1993) [Pubmed]
  29. Mast cells and pulmonary fibrosis. Identification of a histamine releasing factor in bronchoalveolar lavage fluid. Broide, D.H., Smith, C.M., Wasserman, S.I. J. Immunol. (1990) [Pubmed]
  30. Animal model of human disease. Diffuse interstitial pulmonary fibrosis. Pulmonary fibrosis in mice induced by treatment with butylated hydroxytoluene and oxygen. Haschek, W.M., Brody, A.R., Klein-Szanto, A.J., Witschi, H. Am. J. Pathol. (1981) [Pubmed]
  31. Immunolocalization of SPARC, tenascin, and thrombospondin in pulmonary fibrosis. Kuhn, C., Mason, R.J. Am. J. Pathol. (1995) [Pubmed]
  32. Inhibition of bleomycin-induced pulmonary fibrosis by nordihydroguaiaretic acid. The role of alveolar macrophage activation and mediator production. Phan, S.H., Kunkel, S.L. Am. J. Pathol. (1986) [Pubmed]
WikiGenes - Universities